Dr. Jeff Kingsley received his Bachelor of Science degree from the University of Scranton in 1995 with concentrations in biology, chemistry, history, and cultural anthropology, and his Master of Science degree in 1997 in biochemistry. His medical degree was received from the Philadelphia College of Osteopathic Medicine in 2001 and his MBA was received from Emory University’s Goizueta Business School in 2011.
Dr. Kingsley has been faculty with the Columbus Regional Health Family Medicine Residency as well asDirector of Family Medicine and Urgent Care.He currently holds faculty appointments with the Mercer School of Medicine and thePhiladelphia College of Osteopathic Medicine Georgia.
Dr. Kingsley is founder and CEO of IACT Health, a research management organization, and 15 wholly owned and integrated clinical research offices in multiple cities in two states. The family of companies conduct phase Ib through IV research in nearly every medical specialty; inpatient and outpatient; pharmaceutical, biotechnology, and medical device. He has dedicated his career to clinical research since 2006.
Dr. Kingsley is the past Chair of the Board of Trustees for the Association for Clinical Research Professionals which represents more than 13,000 clinical research professionals internationally. He is the former Treasurer for ACRP and APCR, Past President of ABSAME, sits on three additional Boards, and participates on numerous other local, national, and international committees. Dr. Kingsley obtained his CPI in 2009 and his FACRP in 2017.
He enjoys each day with his wife Christine and four beautiful children.Dr. Jeff Kingsley can be reached at 706-536-6619 and [email protected]
Elizabeth Kunkoski Branch Chief, FDA
Isaac R. Rodriguez-Chavez, Ph.D., MH.Sc., M.Sc. FDA Officer, Clinical Research Methodology, Regulatory Compliance and Policy Development, FDA/CDER
Candace Saldarini, M.D. Applied Innovation and Process Improvement, OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION, INC.
Dr. Alka Shaunik, is a leader in Global Medical Affairs at Sanofi with extensive experience as practicing physician and in clinical research in academia and pharmaceutical industry. She has authored numerous research publications, received industry awards, and is a peer reviewer for leading medical journals. She has experience leading phase 3 and 4 studies, and guiding launch of several successful drugs. Her current focus is real world evidence using innovative study designs and health analytics using big data, machine learning and AI methodologies. By emphasizing appropriate methods of data generation and analyses, she champions the continuum of evidence based medicine and data generation to support effectiveness and safety profile of therapies throughout their life cycle.
Michael Song Pharmaceutical Device and Digital Health, MEDIMMUNE
Michael Sparozic Operation Manager and Leader, Trial Supplies, SANOFI